ITRM20000491A0 - Formulazione farmaceutica di propionato di fluticasone. - Google Patents

Formulazione farmaceutica di propionato di fluticasone.

Info

Publication number
ITRM20000491A0
ITRM20000491A0 IT2000RM000491A ITRM20000491A ITRM20000491A0 IT RM20000491 A0 ITRM20000491 A0 IT RM20000491A0 IT 2000RM000491 A IT2000RM000491 A IT 2000RM000491A IT RM20000491 A ITRM20000491 A IT RM20000491A IT RM20000491 A0 ITRM20000491 A0 IT RM20000491A0
Authority
IT
Italy
Prior art keywords
pharmaceutical formulation
fluticasone propionate
fluticasone
propionate
formulation
Prior art date
Application number
IT2000RM000491A
Other languages
English (en)
Inventor
Alan Leslie Cripps
Paul Johnson
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27255761&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITRM20000491(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9921396.9A external-priority patent/GB9921396D0/en
Priority claimed from GB0014451A external-priority patent/GB0014451D0/en
Priority claimed from GB0018654A external-priority patent/GB0018654D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ITRM20000491A0 publication Critical patent/ITRM20000491A0/it
Publication of ITRM20000491A1 publication Critical patent/ITRM20000491A1/it
Application granted granted Critical
Publication of IT1317904B1 publication Critical patent/IT1317904B1/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
IT2000RM000491A 1999-09-11 2000-09-11 Formulazione farmaceutica di propionato di fluticasone. IT1317904B1 (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9921396.9A GB9921396D0 (en) 1999-09-11 1999-09-11 Pharmaceutical formulation
GB0014451A GB0014451D0 (en) 2000-06-13 2000-06-13 Pharmaceutical formulation
GB0018654A GB0018654D0 (en) 2000-07-28 2000-07-28 Pharmaceutical formulation

Publications (3)

Publication Number Publication Date
ITRM20000491A0 true ITRM20000491A0 (it) 2000-09-11
ITRM20000491A1 ITRM20000491A1 (it) 2002-03-11
IT1317904B1 IT1317904B1 (it) 2003-07-15

Family

ID=27255761

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000RM000491A IT1317904B1 (it) 1999-09-11 2000-09-11 Formulazione farmaceutica di propionato di fluticasone.

Country Status (12)

Country Link
US (4) US6479035B1 (it)
EP (1) EP1143930B8 (it)
JP (1) JP2003509359A (it)
AT (1) ATE343374T1 (it)
AU (1) AU7026800A (it)
CA (1) CA2317999C (it)
DE (1) DE60031504T2 (it)
ES (1) ES2274803T3 (it)
FR (4) FR2798290B1 (it)
GB (1) GB2354007B (it)
IT (1) IT1317904B1 (it)
WO (1) WO2001019342A2 (it)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9814717D0 (en) * 1998-02-23 1998-09-02 Bespak Plc Improvements in drug delivery devices
IT1317904B1 (it) * 1999-09-11 2003-07-15 Glaxo Group Ltd Formulazione farmaceutica di propionato di fluticasone.
AU2206801A (en) * 1999-12-24 2001-07-09 Alan Leslie Cripps Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317720B1 (it) * 2000-01-07 2003-07-15 Chiesi Farma Spa Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
EP1465869B1 (en) 2001-12-21 2013-05-15 Exelixis Patent Company LLC Modulators of lxr
EP1321159A1 (en) * 2001-12-21 2003-06-25 CHIESI FARMACEUTICI S.p.A. Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
MXPA04008372A (es) * 2002-03-01 2004-11-26 Chiesi Farma Spa Formulacion superfina de formoterol.
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US8367734B1 (en) 2005-08-11 2013-02-05 Amphastar Pharmaceuticals Inc. Stable epinephrine suspension formulation with high inhalation delivery efficiency
ES2432361T3 (es) * 2005-12-02 2013-12-03 Bayer Healthcare, Llc Derivados de pirrolotriazina útiles para el tratamiento de cáncer por inhibición de cinasa Aurora
GB0712454D0 (en) * 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
EP3403654B1 (en) 2009-10-01 2019-07-31 Adare Development I, L.P. Orally administered corticosteroid compositions
TWI399202B (zh) 2011-03-17 2013-06-21 Intech Biopharm Ltd 製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法
GB201108039D0 (en) * 2011-05-13 2011-06-29 Mexichem Amanco Holding Sa Compositions
CN102379846B (zh) * 2011-10-21 2014-07-02 江苏长风药业有限公司 以氢氟烷烃和聚乙二醇为辅料氟替卡松丙酸酯气雾剂制剂
RU2663117C2 (ru) 2012-05-08 2018-08-01 Никокс Офтэлмикс, Инк. Препараты гидрофобных терапевтических средств, способы их получения и применения
US8765725B2 (en) 2012-05-08 2014-07-01 Aciex Therapeutics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
US9815865B2 (en) 2013-01-07 2017-11-14 Nicox Ophthalmics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
TWI777515B (zh) 2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
EP3797964B1 (en) 2019-09-26 2023-06-07 Presspart Manufacturing S.A. Injection molding tool for metered dose inhaler
US20230271770A1 (en) * 2020-04-21 2023-08-31 Amphastar Pharmaceuticals, Inc. Anti-Viral Pharmaceutical Formulations Administered Via Devices for Lung Targeted Delivery

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL289785A (it) * 1962-11-29
CH634480A5 (de) * 1977-11-25 1983-02-15 Schwarzkopf Gmbh Hans Unter druck stehendes aerosolpraeparat.
DE2949933A1 (de) 1979-12-12 1981-06-19 Wabco Fahrzeugbremsen Gmbh, 3000 Hannover Vorrichtung zum verhindern von schlingerbewegungen eines anhaengers
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5270305A (en) * 1989-09-08 1993-12-14 Glaxo Group Limited Medicaments
GB2235627B (en) 1989-09-08 1993-09-01 Glaxo Group Ltd Inhalation medicaments for treating respiratory disorders
IL95590A (en) 1989-09-08 1996-06-18 Glaxo Group Ltd Medicinal preparations containing Salmetrol and Pluticasone Propionate
US5919827A (en) * 1990-07-11 1999-07-06 Sepracor Inc. Method for treating asthma using optically pure R(-) salmeterol
JP2769925B2 (ja) 1990-10-18 1998-06-25 ミネソタ マイニング アンド マニュファクチャリング カンパニー ベクロメタゾン17,21ジプロピオネートを含んで成るエアロゾル製剤
MX9203481A (es) * 1990-10-18 1992-07-01 Minnesota Mining & Mfg Formulaciones.
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
DK0616525T3 (da) 1991-12-12 1996-01-08 Glaxo Group Ltd Medikamenter
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
RO117414B1 (ro) 1992-12-09 2002-03-29 Jager Paul D Waterbury Compozitie farmaceutica de aerosol in solutie
GB9313650D0 (en) * 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
DE4446891A1 (de) * 1994-12-27 1996-07-04 Falk Pharma Gmbh Stabile wäßrige Budesonid-Lösung
ES2179190T3 (es) 1995-04-14 2003-01-16 Smithkline Beecham Corp Inhalador dosificador para propianato de fluticasona.
IES970858A2 (en) * 1996-12-04 1998-08-12 Bioglan Ireland R & D Ltd Pharmaceutical compositions and devices for their administration
DE59804534D1 (de) * 1997-02-05 2002-07-25 Jago Res Ag Muttenz Medizinische aerosolformulierungen
GB2326334A (en) 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
GB2332372B (en) * 1997-12-08 2002-08-14 Minnesota Mining & Mfg Pharmaceutical aerosol compositions
AU738828B2 (en) 1998-04-30 2001-09-27 3M Innovative Properties Company Metered-dose valve for pharmaceutical aerosol
ATE253896T1 (de) 1998-06-18 2003-11-15 Boehringer Ingelheim Pharma Zwei oder mehrere wirkstoffe enthaltende pharmazeutische aerosolformulierungen
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
ES2234266T3 (es) * 1998-07-24 2005-06-16 Jago Research Ag Formulaciones medicas para aerosoles.
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
GB9903759D0 (en) 1999-02-18 1999-04-14 Novartis Ag Organic compounds
US6231519B1 (en) * 1999-05-04 2001-05-15 Nokia Corporation Method and apparatus for providing air quality analysis based on human reactions and clustering methods
US6315985B1 (en) * 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1317904B1 (it) * 1999-09-11 2003-07-15 Glaxo Group Ltd Formulazione farmaceutica di propionato di fluticasone.
ATE286716T1 (de) 1999-11-23 2005-01-15 Glaxo Group Ltd Pharmazeutische formulierungen enthaltend salmeterol
GB0002798D0 (en) 2000-02-09 2000-03-29 Glaxo Group Ltd Actuator nozzle for metered dose inhaler

Also Published As

Publication number Publication date
US6630129B2 (en) 2003-10-07
US6479035B1 (en) 2002-11-12
FR2848453A1 (fr) 2004-06-18
FR2820322B1 (fr) 2005-03-11
FR2843882B1 (fr) 2011-04-22
US20030086876A1 (en) 2003-05-08
GB0022222D0 (en) 2000-10-25
EP1143930A3 (en) 2002-09-11
ES2274803T3 (es) 2007-06-01
FR2798290B1 (fr) 2003-09-12
WO2001019342A2 (en) 2001-03-22
FR2843882A1 (fr) 2004-03-05
FR2820322A1 (fr) 2002-08-09
US20040157815A1 (en) 2004-08-12
EP1143930B1 (en) 2006-10-25
CA2317999C (en) 2004-11-09
US20040037783A1 (en) 2004-02-26
ATE343374T1 (de) 2006-11-15
EP1143930B8 (en) 2008-03-19
DE60031504T2 (de) 2007-04-05
ITRM20000491A1 (it) 2002-03-11
AU7026800A (en) 2001-04-17
US7220403B2 (en) 2007-05-22
GB2354007B (en) 2003-10-22
FR2798290A1 (fr) 2001-03-16
FR2848453B1 (fr) 2010-09-03
EP1143930A2 (en) 2001-10-17
GB2354007A (en) 2001-03-14
IT1317904B1 (it) 2003-07-15
WO2001019342A3 (en) 2001-08-09
JP2003509359A (ja) 2003-03-11
CA2317999A1 (en) 2001-03-11
DE60031504D1 (de) 2006-12-07

Similar Documents

Publication Publication Date Title
ITRM20000491A0 (it) Formulazione farmaceutica di propionato di fluticasone.
NO20022998L (no) Farmasöytiske preparater som tilveiebringer foröket konsentrasjon av medikament
PT1221918E (pt) Administracao de drogas sub-tenon
ITTO20010008A0 (it) Formulazione farmaceutica
NO20033384L (no) Farmasoytisk formulering
DK1073417T3 (da) Farmaceutisk aerosolformulering
NO20033556D0 (no) Farmasöytiske preparater
IS5953A (is) Lyfjablöndur úr örgerðum eplerenonum
NO20071303L (no) Farmasoytiske preparater
NO20033785L (no) Farmasöytisk formulering
NO20020304L (no) Konserverte farmasoytiske preparater
NO20020086D0 (no) Smaksmaskerte farmasöytiske flytende formuleringer
NO20035627D0 (no) Farmasöytisk formulering
NO20015670D0 (no) Forbedrede farmasöytiske formuleringer
NO20040047L (no) Farmasoytisk formulering for intramuskulaer administrering av fulvestrant
NO20014926L (no) Farmasöytiske forbindelser
FR2802423B1 (fr) Compositions pharmaceutiques
NO20041485L (no) Farmasoytisk formulering omfattende (R)-bicalutamid
DK1227817T3 (da) Ciclesonid-holdigt vandigt farmaceutisk præparat
AR025867A1 (es) Formulacion portasdora farmaceutica
NO20016430L (no) Farmasöytisk kompleks
NO20004816D0 (no) Ny farmasøytisk formulering
GB2392164B (en) Pharmaceutical formulation of fluticasone propionate
IT1316440B1 (it) Cannula erogatrice di unguenti medicinali.
GB0312326D0 (en) Pharmaceutical formulation of fluticasone propionate